Frank Sandmann

1.8k total citations
30 papers, 341 citations indexed

About

Frank Sandmann is a scholar working on Economics and Econometrics, Infectious Diseases and Modeling and Simulation. According to data from OpenAlex, Frank Sandmann has authored 30 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 9 papers in Infectious Diseases and 9 papers in Modeling and Simulation. Recurrent topics in Frank Sandmann's work include Health Systems, Economic Evaluations, Quality of Life (11 papers), COVID-19 epidemiological studies (9 papers) and Healthcare Policy and Management (6 papers). Frank Sandmann is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (11 papers), COVID-19 epidemiological studies (9 papers) and Healthcare Policy and Management (6 papers). Frank Sandmann collaborates with scholars based in United Kingdom, Germany and Sweden. Frank Sandmann's co-authors include Mark Jit, Julie V. Robotham, W. John Edmunds, Sarah R Deeny, Marc Koopmanschap, M Franken, Rosanna C. Barnard, Yang Liu, Carl A. B. Pearson and Stefan Flasche and has published in prestigious journals such as Clinical Infectious Diseases, Thorax and Journal of Theoretical Biology.

In The Last Decade

Frank Sandmann

27 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Sandmann United Kingdom	12	124	86	84	66	57	30	341
Yu‐Lin Tai Taiwan	10	209 1.7×	44 0.5×	73 0.9×	88 1.3×	76 1.3×	18	465
Kifle Lentiro Ethiopia	7	164 1.3×	49 0.6×	62 0.7×	100 1.5×	26 0.5×	8	337
Hakjun Hyun South Korea	10	208 1.7×	32 0.4×	69 0.8×	84 1.3×	59 1.0×	38	379
Sharon Hui Xuan Tan Singapore	9	354 2.9×	53 0.6×	45 0.5×	41 0.6×	62 1.1×	24	597
Tilahun Yemanu Birhan Ethiopia	8	154 1.2×	42 0.5×	123 1.5×	87 1.3×	15 0.3×	19	345
Sami Almudarra Saudi Arabia	9	109 0.9×	30 0.3×	54 0.6×	44 0.7×	64 1.1×	22	303
Emily McGibbon United States	9	215 1.7×	27 0.3×	132 1.6×	107 1.6×	43 0.8×	17	421
Tristan Delory France	13	102 0.8×	31 0.4×	33 0.4×	115 1.7×	48 0.8×	44	465
Melissa Briggs‐Hagen United States	9	267 2.2×	26 0.3×	36 0.4×	57 0.9×	59 1.0×	16	374
Meredith Haddix United States	10	203 1.6×	25 0.3×	51 0.6×	118 1.8×	73 1.3×	15	337

Countries citing papers authored by Frank Sandmann

Since Specialization

Citations

This map shows the geographic impact of Frank Sandmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Sandmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Sandmann more than expected).

Fields of papers citing papers by Frank Sandmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Sandmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Sandmann. The network helps show where Frank Sandmann may publish in the future.

Co-authorship network of co-authors of Frank Sandmann

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Sandmann. A scholar is included among the top collaborators of Frank Sandmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Sandmann. Frank Sandmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sandmann, Frank, et al.. (2026). Social mixing and time use throughout the year: Potential changes in disease transmission and age distribution of cases. Journal of Theoretical Biology. 622. 112349–112349.

Krauer, Fabienne, Marina Treskova, Mihály Koltai, et al.. (2024). Effectiveness and efficiency of immunisation strategies to prevent RSV among infants and older adults in Germany: a modelling study. BMC Medicine. 22(1). 478–478. 2 indexed citations

Robert, Alexis, Lloyd A. C. Chapman, Frank Sandmann, et al.. (2024). Predicting subnational incidence of COVID-19 cases and deaths in EU countries. BMC Infectious Diseases. 24(1). 204–204. 4 indexed citations

Torres‐Rueda, Sergio, Anna Vassall, Maarten Jansen, et al.. (2024). The Use of Evidence to Design an Essential Package of Health Services in Pakistan: A Review and Analysis of Prioritisation Decisions at Different Stages of the Appraisal Process. International Journal of Health Policy and Management. 13. 8043–8043. 1 indexed citations

Vardavas, Constantine, Katerina Nikitara, Revati Phalkey, et al.. (2023). Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU/UK/OECD: a systematic review. BMJ Open. 13(10). e077602–e077602. 16 indexed citations

Turner, Hugo C., Frank Sandmann, Laura Downey, et al.. (2023). What are economic costs and when should they be used in health economic studies?. Cost Effectiveness and Resource Allocation. 21(1). 31–31. 24 indexed citations

Sandmann, Frank, et al.. (2023). Seasonality of acute kidney injury phenotypes in England: an unsupervised machine learning classification study of electronic health records. BMC Nephrology. 24(1). 234–234. 4 indexed citations

Tildesley, Michael J., Anna Vassall, Steven Riley, et al.. (2022). Optimal health and economic impact of non-pharmaceutical intervention measures prior and post vaccination in England: a mathematical modelling study. Royal Society Open Science. 9(8). 211746–211746. 14 indexed citations

Sandmann, Frank, Elise Tessier, Joanne Lacy, et al.. (2022). Long-Term Health-Related Quality of Life in Non-Hospitalized Coronavirus Disease 2019 (COVID-19) Cases With Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in England: Longitudinal Analysis and Cross-Sectional Comparison With Controls. Clinical Infectious Diseases. 75(1). e962–e973. 36 indexed citations

10.

Liu, Yang, Carl A. B. Pearson, Frank Sandmann, et al.. (2022). Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis. The Lancet Regional Health - Europe. 17. 100381–100381. 18 indexed citations

11.

Sandmann, Frank, Mark Jit, Nick Andrews, et al.. (2021). Evaluating the impact of a continued maternal pertussis immunisation programme in England: A modelling study and cost-effectiveness analysis. Vaccine. 39(32). 4500–4509. 5 indexed citations

12.

Liu, Yang, Frank Sandmann, Rosanna C. Barnard, et al.. (2021). Optimising health and economic impacts of COVID-19 vaccine prioritisation strategies in the WHO European Region: a mathematical modelling study. The Lancet Regional Health - Europe. 12. 100267–100267. 29 indexed citations

13.

Sandmann, Frank, Mary Ramsay, W. John Edmunds, Yoon Hong Choi, & Mark Jit. (2021). How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations. Value in Health. 24(10). 1391–1399. 1 indexed citations

14.

Gilson, Richard, Diarmuid Nugent, Kate Bennett, et al.. (2020). Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT. Health Technology Assessment. 24(47). 1–86. 21 indexed citations

15.

Ankcorn, Michael, et al.. (2019). Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation. Value in Health. 23(3). 309–318. 6 indexed citations

16.

Sandmann, Frank, Mark Jit, Julie V. Robotham, & Sarah R Deeny. (2017). Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11–2015/16. Journal of Hospital Infection. 97(1). 79–85. 11 indexed citations

17.

Gerber‐Grote, Andreas, Frank Sandmann, Min Zhou, et al.. (2014). Decision making in Germany: Is health economic evaluation as a supporting tool a sleeping beauty?. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 108(7). 390–396. 14 indexed citations

18.

Mostardt, Sarah, et al.. (2014). Standard Costs for Health Economic Evaluations: An International Comparison. Value in Health. 17(7). A427–A427. 3 indexed citations

19.

Sandmann, Frank, M Franken, Adri Steenhoek, & Marc Koopmanschap. (2013). Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time. Health Policy. 112(3). 285–296. 6 indexed citations

20.

Franken, M, Fredrik Nilsson, Frank Sandmann, Anthonius de Boer, & Marc Koopmanschap. (2013). Unravelling Drug Reimbursement Outcomes: A Comparative Study of the Role of Pharmacoeconomic Evidence in Dutch and Swedish Reimbursement Decision Making. PharmacoEconomics. 31(9). 781–797. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact